Development of (G3-C12)-mediated camptothecin polymeric prodrug targeting to Galectin-3 receptor against androgen-independent prostate cancer. [electronic resource]
Producer: 20210115Description: 119123 p. digitalISSN:- 1873-3476
- Animals
- Blood Proteins -- metabolism
- Camptothecin -- administration & dosage
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Drug Delivery Systems -- methods
- Drug Development -- methods
- Galectins -- metabolism
- Humans
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Polymers -- administration & dosage
- Prodrugs -- administration & dosage
- Prostatic Neoplasms, Castration-Resistant -- drug therapy
- Xenograft Model Antitumor Assays -- methods
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.